Antibody-Recruiting Molecules: An Emerging Paradigm for Engaging Immune Function in Treating Human Disease

被引:119
作者
McEnaney, Patrick J. [1 ]
Parker, Christopher G. [1 ]
Zhang, Andrew X. [1 ]
Spiegel, David A. [1 ,2 ]
机构
[1] Yale Univ, Dept Chem, New Haven, CT 06520 USA
[2] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA
关键词
RECEPTOR-TARGETED IMMUNOTHERAPY; PROTEIN-PROTEIN INTERACTIONS; LASTING ANTITUMOR IMMUNITY; GROWTH-FACTOR RECEPTOR; ALPHA-V INTEGRINS; FC-GAMMA-R; PLASMINOGEN-ACTIVATOR; MONOCLONAL-ANTIBODIES; BISPECIFIC ANTIBODIES; MULTIVALENT LIGANDS;
D O I
10.1021/cb300119g
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Synthetic immunology, the development of synthetic systems capable of modulating and/or manipulating immunological functions, represents an emerging field of research with manifold possibilities. One focus of this area has been to create low molecular weight synthetic species, called antibody-recruiting molecules (ARMs), which are capable of enhancing antibody binding to disease-relevant cells or viruses, thus leading to their immune-mediated clearance. This article provides a thorough discussion of contributions in this area, beginning with the history of small-molecule-based technologies for modulating antibody recognition, followed by a systematic review of the various applications of ARM-based strategies. Thus, we describe ARMs capable of targeting cancer, bacteria, and viral pathogens, along with some of the scientific discoveries that have resulted from their development. Research in this area underscores the many exciting possibilities at the interface of organic chemistry and immunobiology and is positioned to advance both basic and clinical science in the years to come.
引用
收藏
页码:1139 / 1151
页数:13
相关论文
共 179 条
[51]   INVITRO SELECTION OF RNA MOLECULES THAT BIND SPECIFIC LIGANDS [J].
ELLINGTON, AD ;
SZOSTAK, JW .
NATURE, 1990, 346 (6287) :818-822
[52]  
FARAH FS, 1973, IMMUNOLOGY, V25, P217
[53]   Integrin adhesion receptors in tumor metastasis [J].
Felding-Habermann, B .
CLINICAL & EXPERIMENTAL METASTASIS, 2003, 20 (03) :203-213
[54]   cAC10-vcMMAE, an anti-CD30-monomethyl auristatin E conjugate with potent and selective antitumor activity [J].
Francisco, JA ;
Cerveny, CG ;
Meyer, DL ;
Mixan, BJ ;
Klussman, K ;
Chace, DF ;
Rejniak, SX ;
Gordon, KA ;
DeBlanc, R ;
Toki, BE ;
Law, CL ;
Doronina, SO ;
Siegall, CB ;
Senter, PD ;
Wahl, AF .
BLOOD, 2003, 102 (04) :1458-1465
[55]   A UNIQUE NATURAL HUMAN-IGG ANTIBODY WITH ANTI-ALPHA-GALACTOSYL SPECIFICITY [J].
GALILI, U ;
RACHMILEWITZ, EA ;
PELEG, A ;
FLECHNER, I .
JOURNAL OF EXPERIMENTAL MEDICINE, 1984, 160 (05) :1519-1531
[56]   EVOLUTIONARY RELATIONSHIP BETWEEN THE NATURAL ANTI-GAL ANTIBODY AND THE GAL-ALPHA-1-]3GAL EPITOPE IN PRIMATES [J].
GALILI, U ;
CLARK, MR ;
SHOHET, SB ;
BUEHLER, J ;
MACHER, BA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (05) :1369-1373
[57]   Loss of CD4 T-cell-dependent tolerance to proteins with modified amino acids [J].
Gauba, Varun ;
Gruenewald, Jan ;
Gorney, Vanessa ;
Deaton, Lisa M. ;
Kang, Mingchao ;
Bursulaya, Badry ;
Ou, Weijia ;
Lerner, Richard A. ;
Schmedt, Christian ;
Geierstanger, Bernhard H. ;
Schultz, Peter G. ;
Ramirez-Montagut, Teresa .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (31) :12821-12826
[58]   Potent Inhibition of HIV-1 Entry with a Chemically Programmed Antibody Aided by an Efficient Organocatalytic Synthesis [J].
Gavrilyuk, Julia ;
Uehara, Hisatoshi ;
Otsubo, Nobumasa ;
Hessell, Ann ;
Burton, Dennis R. ;
Barbas, Carlos F., III .
CHEMBIOCHEM, 2010, 11 (15) :2113-2118
[59]   An efficient chemical approach to bispecific antibodies and antibodies of high valency [J].
Gavrilyuk, Julia I. ;
Wuellner, Ulrich ;
Salahuddin, Syed ;
Goswami, Rajib K. ;
Sinha, Subhash C. ;
Barbas, Carlos F., III .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (14) :3716-3720
[60]   β-Lactam-based approach for the chemical programming of aldolase antibody 38C2 [J].
Gavrilyuk, Julia I. ;
Wuellner, Ulrich ;
Barbas, Carlos F., III .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (05) :1421-1424